Nonclinical evaluation of HBG1/2 and BCL11A as genome-editing targets for the treatment of β-hemoglobinopathies

Nonclinical evaluation of HBG1/2 and BCL11A as genome-editing targets for the treatment of β-hemoglobinopathies

Saved in:

Bibliographic Details
Main Authors:	Tusneem Janoudi, Mrunali Jagdale, Meng Wu, Sanjana Gorlla, Peisheng Zhang, Ying Shao, Li Li, Sheryl R. Bowley, Eugenio Marco, Kai-Hsin Chang
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Blood Advances
Online Access:	http://www.sciencedirect.com/science/article/pii/S2473952924007055
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathies
by: Prathibha Babu Chandraprabha, et al.
Published: (2024-12-01)

Removal of promoter CpG methylation by epigenome editing reverses HBG silencing
by: Henry W. Bell, et al.
Published: (2025-07-01)

Genetic Modifiers of HbF in HbAA and HbAS Women From São Tomé e Príncipe: An Association Study of Common Genetic Variants in BCL11A, MYB, HBG2, and BGLT3
by: Licínio Manco, et al.
Published: (2025-06-01)

Base editing HbS to HbG-Makassar improves hemoglobin function supporting its use in sickle cell disease
by: Zachary Kostamo, et al.
Published: (2025-02-01)

Updates in Hemoglobinopathies
by: Youssef Al-Tonbary, et al.
Published: (2013-01-01)

PRENATAL DIAGNOSIS OF β-THALASSEMIAS AND HEMOGLOBINOPATHIES
by: Maria Cristina Rosatelli, et al.
Published: (2009-11-01)

PRENATAL DIAGNOSIS OF β-THALASSEMIAS AND HEMOGLOBINOPATHIES
by: Luisella Saba, et al.
Published: (2009-06-01)

The case of hemoglobinopathy E
by: Yu. I. Kunakov, et al.
Published: (2014-07-01)

INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES
by: Deborah Rund, et al.
Published: (2009-06-01)

Psychosis proneness, loneliness, and hallucinations in nonclinical individuals.
by: Sarah Hope Lincoln, et al.
Published: (2021-01-01)

A one-base therapeutic insertion in the HBG2 distal promoter reactivates γ-globin expression
by: Xiuqin Bao, et al.
Published: (2025-03-01)

Nonclinical strategies and considerations to enable the redosing of gene therapies
by: Jeffrey S. Moffit, et al.
Published: (2025-09-01)

Preparation of a Nonclinical Overview Based on Scientific Literature
by: G. N. Engalycheva, et al.
Published: (2021-12-01)

EVOLUTION OF HEMOGLOBINOPATHY PREVENTION IN AFRICA
by: Slaheddine Fattoum
Published: (2009-10-01)

Fetomaternal outcome of pregnancy with hemoglobinopathy
by: Bivarani Goswami, et al.
Published: (2024-05-01)

Epidemiologic profile of hemoglobinopathies in Benin
by: Selma Gomez, et al.
Published: (2024-12-01)

GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES
by: Laura Breda, et al.
Published: (2009-11-01)

Changes of hemostatic factors in patients with hemoglobinopathies
by: A F Oner, et al.
Published: (1999-07-01)

Nonclinical study of the new immunotropic drug effectiveness in salmonella infection treatment
by: M. G. Teymurazov, et al.
Published: (2021-07-01)

Feasibility of a synchronous, online, group psychological intervention in nonclinical settings
by: Flavia Arrigoni, et al.
Published: (2024-12-01)

Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product
by: Neungseon Seo, et al.
Published: (2024-11-01)

Validation studies on migraine diagnostic tools for use in nonclinical settings: a systematic review
by: Du Wei, et al.
Published: (2023-04-01)

The Clinical and Nonclinical Values of Nonexercise Estimation of Cardiovascular Endurance in Young Asymptomatic Individuals
by: Mahmoud A. Alomari, et al.
Published: (2012-01-01)

Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies
by: Wen-Ting K. Tsai, et al.
Published: (2024-12-01)

Pregnancy with a Severe Hemoglobinopathy: Unintended Consequences of Transfusions
by: David Kim, et al.
Published: (2013-01-01)

In vitro inhibition of BCL11A gene expression by RNAi for the Treatment of ?-Thalassemia
by: Vikas Urkude, et al.
Published: (2014-08-01)

A platform approach as a plausible option for nonclinical safety assessment of adjuvanted vaccines
by: Eric Destexhe
Published: (2025-08-01)

Efficacy of different AV7909 dose regimens in a nonclinical model of pulmonary anthrax
by: Lisa Henning, et al.
Published: (2023-12-01)

BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice
by: Yoonjeong Jang, et al.
Published: (2025-06-01)

Analyzing inhibition of BCL11A gene expression in K562 cells by RNAi
by: Vikas Urkude
Published: (2014-08-01)

Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
by: Gangling Xu, et al.
Published: (2025-08-01)

Tetracycline-Resistant Genes in Escherichia coli from Clinical and Nonclinical Sources in Rivers State, Nigeria
by: Doubra Otis Perewari, et al.
Published: (2022-01-01)

The Changing Landscape of Opportunity for Cure of Severe Hemoglobinopathies in Middle-Income Regions
by: Lawrence Faulkner
Published: (2025-03-01)

Pregnancy Complications in a-Thalassemia (Hemoglobinopathy H): A Case Study
by: Marianna Politou, et al.
Published: (2018-01-01)

Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies
by: rujittika mungmunpuntipantip, et al.
Published: (2022-06-01)

SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
by: Widad Yazaji, et al.
Published: (2016-09-01)

New Eye Drop Formulation Based on Desonide and Xanthan Gum in Dry Eye Disease: Nonclinical Studies
by: Santa Viola, et al.
Published: (2025-02-01)

Analysis of the Transcriptional Control of <i>Bcl11b</i> in Chicken: IRF1 and GATA1 as Negative Regulators
by: Lingling Qiu, et al.
Published: (2025-02-01)

Genetic variants in human BCL2L11 (BIM) are associated with ulcerative forms of Buruli ulcer
by: João Fevereiro, et al.
Published: (2021-01-01)

The influence of childhood abuse, adult life events, and affective temperaments on the well-being of the general, nonclinical adult population
by: Kanai Y, et al.
Published: (2016-04-01)